CUE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.49%

Insider Buying (Last 12 Months): $19,620.00

Insider Selling (Last 12 Months): $0.00

Cue Biopharma Insider Trading History Chart

Cue Biopharma Share Price & Price History

^$0.67

▼ -0.03 (-4.29%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

Cue Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/25/2023	Anish Suri	Insider	Buy	4,000	$2.76	$11,040.00	135,638
8/14/2023	Daniel R. Passeri	CEO	Buy	3,000	$2.86	$8,580.00	134,578
3/23/2023	Peter A Kiener	Director	Sell	9,325	$3.28	$30,586.00	357
5/23/2022	Aaron G.L. Fletcher	Director	Buy	150,000	$3.52	$528,000.00	885,000
3/31/2022	Aaron G.L. Fletcher	Director	Buy	735,000	$4.76	$3,498,600.00	165,000
10/1/2021	Kerri-Ann Millar	CFO	Sell	1,251	$14.21	$17,776.71
9/24/2021	Daniel R. Passeri	CEO	Buy	3,400	$14.72	$50,048.00
9/23/2021	Anish Suri	Insider	Sell	20,000	$15.23	$304,600.00

J.P. Morgan’s DIRE Warning

From Behind the Markets | Ad

When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."

Click here to see why Wall Street is in PANIC mode >>>

SEC Filings (Institutional Ownership Changes) for Cue Biopharma (NASDAQ:CUE)

35.04% of Cue Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cue Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2024	Carlson Capital L P	20,000	$38K	0.0%	-83.3%	0.041%
5/10/2024	Vanguard Group Inc.	2,283,362	$4.32M	0.0%	+7.1%	4.694%
5/9/2024	Monaco Asset Management SAM	334,742	$0.63M	0.2%	-2.2%	0.688%
4/10/2024	Wedmont Private Capital	40,000	$76K	0.0%	+100.0%	0.082%
2/8/2024	Legacy Capital Group California Inc.	10,000	$26K	0.0%	N/A	0.022%
2/7/2024	Monaco Asset Management SAM	342,242	$0.90M	0.3%	-4.9%	0.759%
2/1/2024	Sigma Planning Corp	108,875	$0.29M	0.0%	-55.5%	0.241%
1/18/2024	Navalign LLC	25,000	$66K	0.0%	N/A	0.055%
1/18/2024	Good Life Advisors LLC	100,000	$0.26M	0.0%	-10.7%	0.222%
11/7/2023	Monaco Asset Management SAM	359,739	$0.83M	0.2%	-2.9%	0.800%
11/7/2023	New York State Common Retirement Fund	11,984	$28K	0.0%	-53.4%	0.027%
11/6/2023	Sigma Planning Corp	244,705	$0.56M	0.0%	+8.6%	0.544%
10/24/2023	Channel Wealth LLC	15,300	$35K	0.0%	-77.7%	0.034%
10/13/2023	Sanders Morris Harris LLC	346,212	$0.80M	0.2%	+513.6%	0.770%
9/21/2023	Barclays PLC	12,946	$48K	0.0%	+114.7%	0.029%
8/15/2023	Silverarc Capital Management LLC	403,402	$1.47M	0.5%	+31.7%	0.897%
8/10/2023	Carlson Capital L P	134,036	$0.49M	0.0%	-47.2%	0.310%
8/8/2023	Monaco Asset Management SAM	370,407	$1.35M	0.4%	-20.6%	0.858%
8/4/2023	American International Group Inc.	16,635	$61K	0.0%	N/A	0.039%
8/2/2023	Sigma Planning Corp	225,300	$0.82M	0.0%	+2.0%	0.522%
7/27/2023	Virtu Financial LLC	17,594	$64K	0.0%	N/A	0.041%
7/26/2023	Channel Wealth LLC	68,700	$0.25M	0.1%	+14.4%	0.159%
7/13/2023	Cambridge Investment Research Advisors Inc.	20,000	$73K	0.0%	N/A	0.046%
7/11/2023	Sanders Morris Harris LLC	56,420	$0.20M	0.0%	N/A	0.131%
5/12/2023	Prosight Management LP	1,151,855	$4.11M	1.9%	-37.4%	2.668%
5/8/2023	Sigma Planning Corp	220,889	$0.79M	0.0%	+14.6%	0.512%
5/1/2023	P.A.W. Capital Corp	150,000	$0.54M	1.2%	-16.7%	0.347%
4/27/2023	Channel Wealth LLC	60,050	$0.21M	0.1%	N/A	0.139%
4/18/2023	ETF Managers Group LLC	13,528	$48K	0.0%	N/A	0.031%
2/13/2023	Voss Capital LLC	125,000	$0.36M	0.1%	-37.5%	0.290%
2/13/2023	GSA Capital Partners LLP	188,308	$0.54M	0.1%	-12.9%	0.438%
2/10/2023	Good Life Advisors LLC	75,000	$0.21M	0.0%	+31.6%	0.174%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	22,970	$65K	0.0%	-29.7%	0.053%
2/3/2023	Monaco Asset Management SAM	497,177	$1.42M	0.4%	+8.4%	1.155%
2/1/2023	Bank of Montreal Can	33,900	$98K	0.0%	N/A	0.079%
1/31/2023	Monaco Asset Management SAM	497,177	$1.42M	0.4%	+8.4%	1.155%
1/24/2023	Sigma Planning Corp	192,734	$0.55M	0.0%	+2.3%	0.448%
1/13/2023	Sanders Morris Harris LLC	56,420	$0.16M	0.1%	-93.3%	0.131%
11/15/2022	Prosight Management LP	1,545,573	$3.45M	1.8%	-6.6%	4.368%
11/15/2022	Carlson Capital L P	535,000	$1.19M	0.1%	-7.8%	1.512%
11/14/2022	Annandale Capital LLC	65,000	$0.15M	0.1%	N/A	0.184%
11/14/2022	Ergoteles LLC	117,074	$0.26M	0.0%	-14.2%	0.331%
11/10/2022	Sigma Planning Corp	188,424	$0.42M	0.0%	+12.8%	0.533%
11/10/2022	Nantahala Capital Management LLC	93,297	$0.21M	0.0%	-7.1%	0.264%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	32,677	$73K	0.0%	N/A	0.092%
11/2/2022	Voss Capital LLC	200,000	$0.45M	0.1%	+100.0%	0.565%
11/1/2022	P.A.W. Capital Corp	200,000	$0.45M	0.7%	+14.3%	0.565%
10/31/2022	Monaco Asset Management SAM	458,851	$1.02M	0.4%	+3.4%	1.297%
10/13/2022	Newbridge Financial Services Group Inc.	17,000	$38K	0.0%	+41.7%	0.048%
10/7/2022	Sanders Morris Harris LLC	848,048	$2.02M	0.5%	+15.2%	2.397%
8/16/2022	Delphia USA Inc.	10,126	$25K	0.0%	N/A	0.029%
8/15/2022	Nantahala Capital Management LLC	100,464	$0.25M	0.0%	-95.5%	0.284%
8/13/2022	Voss Capital LLC	100,000	$0.25M	0.1%	N/A	0.283%
8/13/2022	Prosight Management LP	1,655,477	$4.12M	3.2%	+9.6%	4.679%
8/12/2022	Ensign Peak Advisors Inc	17,960	$45K	0.0%	+72.7%	0.051%
8/11/2022	Sigma Planning Corp	167,106	$0.42M	0.0%	+28.8%	0.472%
8/1/2022	Monaco Asset Management SAM	443,851	$1.11M	0.5%	+886.3%	1.255%
7/19/2022	Good Life Advisors LLC	57,000	$0.14M	0.0%	N/A	0.161%
7/15/2022	Newbridge Financial Services Group Inc.	12,000	$30K	0.0%	+200.0%	0.034%
7/13/2022	P.A.W. Capital Corp	175,000	$0.44M	0.6%	+16.7%	0.495%
7/11/2022	Sanders Morris Harris LLC	736,212	$1.80M	0.4%	-15.7%	2.081%
6/30/2022	Amalgamated Bank	5,025	$25K	0.0%	N/A	0.014%
5/17/2022	Prosight Management LP	1,510,282	$7.37M	4.8%	+82.2%	4.270%
5/11/2022	Bleichroeder LP	552,000	$2.69M	0.5%	+176.0%	1.672%
5/11/2022	GSA Capital Partners LLP	96,563	$0.47M	0.1%	-3.3%	0.293%
5/9/2022	WealthShield Partners LLC	29,951	$0.15M	0.0%	+161.7%	0.091%
5/9/2022	Monaco Asset Management SAM	45,000	$0.22M	0.1%	N/A	0.136%
5/4/2022	Advisor Group Holdings Inc.	38,182	$2.41M	0.0%	+43.4%	0.116%
4/21/2022	Virginia Retirement Systems ET AL	11,000	$54K	0.0%	-31.3%	0.033%
4/21/2022	P.A.W. Capital Corp	150,000	$0.73M	0.8%	+25.0%	0.454%
4/20/2022	Sigma Planning Corp	129,728	$0.63M	0.0%	+51.0%	0.393%
4/11/2022	Sanders Morris Harris LLC	873,021	$4.26M	0.8%	+143.1%	2.645%
2/14/2022	GSA Capital Partners LLP	99,816	$1.13M	0.1%	-18.0%	0.314%
2/11/2022	Granite Point Capital Management L.P.	110,000	$1.24M	0.2%	N/A	0.346%
2/11/2022	Ensign Peak Advisors Inc	10,400	$0.12M	0.0%	N/A	0.033%
2/10/2022	Bleichroeder LP	200,000	$2.26M	0.4%	+14.3%	0.630%
2/10/2022	Rafferty Asset Management LLC	97,062	$1.10M	0.0%	+148.8%	0.306%
2/10/2022	WealthShield Partners LLC	11,444	$0.13M	0.0%	-38.5%	0.036%
2/10/2022	Citigroup Inc.	80,185	$0.91M	0.0%	+184.3%	0.252%
2/10/2022	P.A.W. Capital Corp	120,000	$1.36M	1.2%	-4.0%	0.378%
2/9/2022	BNP Paribas Arbitrage SA	21,294	$0.24M	0.0%	+277.9%	0.067%
2/9/2022	Dimensional Fund Advisors LP	849,343	$9.61M	0.0%	+360.1%	2.674%
2/8/2022	Northern Trust Corp	316,467	$3.58M	0.0%	+2.2%	0.996%
2/3/2022	Advisor Group Holdings Inc.	26,620	$0.30M	0.0%	-14.7%	0.084%
2/3/2022	Virginia Retirement Systems ET AL	16,000	$0.18M	0.0%	+29.0%	0.050%
2/2/2022	Sanders Morris Harris LLC	359,113	$4.42M	0.8%	+17.5%	1.131%
2/2/2022	Sigma Planning Corp	85,893	$0.97M	0.0%	+2.0%	0.270%
1/25/2022	Belvedere Trading LLC	19,819	$0.18M	0.0%	N/A	0.062%
11/16/2021	Two Sigma Advisers LP	202,000	$2.94M	0.0%	-32.2%	0.636%
11/16/2021	Two Sigma Investments LP	103,430	$1.51M	0.0%	-48.5%	0.326%
11/15/2021	California State Teachers Retirement System	39,229	$0.57M	0.0%	-4.5%	0.124%
11/15/2021	Marshall Wace LLP	26,340	$0.38M	0.0%	-16.8%	0.083%
11/15/2021	683 Capital Management LLC	743,772	$10.84M	0.4%	+5.6%	2.342%
11/15/2021	Virtus ETF Advisers LLC	15,636	$0.23M	0.1%	-4.9%	0.049%
11/15/2021	Dimensional Fund Advisors LP	184,612	$2.69M	0.0%	+128.7%	0.581%
11/15/2021	GSA Capital Partners LLP	121,727	$1.77M	0.2%	+328.7%	0.383%
11/12/2021	Carlson Capital L P	102,816	$1.50M	0.1%	-31.8%	0.326%
11/12/2021	Prosight Management LP	655,185	$9.55M	5.3%	+3.9%	2.079%
11/12/2021	WealthShield Partners LLC	18,621	$0.27M	0.1%	+76.8%	0.059%
11/12/2021	Macquarie Group Ltd.	8,016	$0.12M	0.0%	+1,164.4%	0.025%

Data available starting January 2016

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient's body. Its lead drug product candidate is CUE-101 for the treatment of human papilloma virus (HPV16+)-driven recurrent/metastatic head and neck cancer. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology; strategic collaboration and option agreement with Ono Pharmaceutical Co., Ltd. to advance CUE-401 for the treatment of autoimmune and inflammatory diseases; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $0.67

$0.67

$0.73

50 Day Range

MA: $1.29

$0.70

$1.91

52 Week Range

Now: $0.67

$0.67

$3.95

Volume

421,831 shs

Average Volume

321,798 shs

Market Capitalization

$32.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.96

Who are the company insiders with the largest holdings of Cue Biopharma?: Cue Biopharma's top insider investors include:
Anish Suri (Insider)
Daniel R Passeri (CEO)
Peter A Kiener (Director)
Learn More about top insider investors at Cue Biopharma.